Beyond Whole-Body Imaging: Advanced Imaging Techniques of PET/MRI

Abstract PET/MRI is a hybrid imaging modality that is gaining clinical interest with the first Food and Drug Administration–approved simultaneous imaging system recently added to the clinical armamentarium. Several advanced PET/MRI applications, such as high-resolution anatomic imaging, diffusion-weighted imaging, motion correction, and cardiac imaging, show great potential for clinical use. The purpose of this article is to highlight several advanced PET/MRI applications through case examples and review of the current literature.

[1]  S. Nekolla,et al.  Hybrid PET/MR Imaging of the Heart: Potential, Initial Experiences, and Future Prospects , 2013, The Journal of Nuclear Medicine.

[2]  N. Schwenzer,et al.  Respiratory Motion Correction in Oncologic PET Using T1-Weighted MR Imaging on a Simultaneous Whole-Body PET/MR System , 2013, The Journal of Nuclear Medicine.

[3]  P. Grigsby,et al.  Tumor volume and subvolume concordance between FDG‐PET/CT and diffusion‐weighted MRI for squamous cell carcinoma of the cervix , 2013, Journal of magnetic resonance imaging : JMRI.

[4]  D. Berman,et al.  Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission tomography. , 2013, Journal of the American College of Cardiology.

[5]  Quanzheng Li,et al.  Magnetic resonance-based motion correction for positron emission tomography imaging. , 2013, Seminars in nuclear medicine.

[6]  T. Jochimsen,et al.  PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner , 2013, Pediatric Radiology.

[7]  Emmanuel Itti,et al.  Whole-body diffusion magnetic resonance imaging in the assessment of lymphoma , 2012, Cancer imaging : the official publication of the International Cancer Imaging Society.

[8]  Markus Schwaiger,et al.  Workflow and Scan Protocol Considerations for Integrated Whole-Body PET/MRI in Oncology , 2012, The Journal of Nuclear Medicine.

[9]  Gerald Antoch,et al.  Oncologic PET/MRI, Part 2: Bone Tumors, Soft-Tissue Tumors, Melanoma, and Lymphoma , 2012, The Journal of Nuclear Medicine.

[10]  Ciprian Catana,et al.  MRI-Based Nonrigid Motion Correction in Simultaneous PET/MRI , 2012, The Journal of Nuclear Medicine.

[11]  F. Forrer,et al.  Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography , 2012, European Radiology.

[12]  G. Antoch,et al.  Oncologic PET/MRI, Part 1: Tumors of the Brain, Head and Neck, Chest, Abdomen, and Pelvis , 2012, The Journal of Nuclear Medicine.

[13]  A. Drzezga,et al.  First Clinical Experience with Integrated Whole-Body PET/MR: Comparison to PET/CT in Patients with Oncologic Diagnoses , 2012, The Journal of Nuclear Medicine.

[14]  I. Burger,et al.  PET/MR imaging of bone lesions – implications for PET quantification from imperfect attenuation correction , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[15]  M. Uder,et al.  Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  S. Alberts,et al.  Treatment advances in liver-limited metastatic colorectal cancer. , 2011, Clinical colorectal cancer.

[17]  T Schaeffter,et al.  Fast generation of 4D PET-MR data from real dynamic MR acquisitions , 2011, Physics in medicine and biology.

[18]  A. Padhani,et al.  Bony metastases: assessing response to therapy with whole-body diffusion MRI , 2011, Cancer imaging : the official publication of the International Cancer Imaging Society.

[19]  Z. Fayad,et al.  MRI-based motion correction of thoracic PET: initial comparison of acquisition protocols and correction strategies suitable for simultaneous PET/MRI systems , 2011, European Radiology.

[20]  Myeong-Jin Kim,et al.  F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for the Detection of Colorectal Liver Metastases , 2011 .

[21]  Pek-Lan Khong,et al.  Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma. , 2011, AJR. American journal of roentgenology.

[22]  Ilja Bezrukov,et al.  MRI-Based Attenuation Correction for Whole-Body PET/MRI: Quantitative Evaluation of Segmentation- and Atlas-Based Methods , 2011, The Journal of Nuclear Medicine.

[23]  Ernst J. Rummeny,et al.  Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[24]  L. Johansson,et al.  Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients , 2011, Acta radiologica.

[25]  J. Stoker,et al.  Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. , 2010, Radiology.

[26]  J. Usuda,et al.  Cine MRI enables better therapeutic planning than CT in cases of possible lung cancer chest wall invasion. , 2010, Lung cancer.

[27]  S. Vandenberghe,et al.  MRI-Based Attenuation Correction for PET/MRI Using Ultrashort Echo Time Sequences , 2010, Journal of Nuclear Medicine.

[28]  T. Baysal,et al.  Diffusion-weighted magnetic resonance imaging in differentiation of postobstructive consolidation from central lung carcinoma. , 2009, Magnetic resonance imaging.

[29]  Heiko Schöder,et al.  Hybrid imaging (SPECT/CT and PET/CT): improving therapeutic decisions. , 2009, Seminars in nuclear medicine.

[30]  S. Matsumoto,et al.  Detection of bone metastases in non‐small cell lung cancer patients: Comparison of whole‐body diffusion‐weighted imaging (DWI), whole‐body MR imaging without and with DWI, whole‐body FDG‐PET/CT, and bone scintigraphy , 2009, Journal of magnetic resonance imaging : JMRI.

[31]  Dae Chul Jung,et al.  Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients. , 2009, European journal of cancer.

[32]  E. Abdalla,et al.  Curable metastatic colorectal cancer: Recommended paradigms , 2009, Current oncology reports.

[33]  H. Oizumi,et al.  Role of diffusion-weighted magnetic resonance imaging for predicting of tumor invasiveness for clinical stage IA non-small cell lung cancer. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[34]  Nassir Navab,et al.  Tissue Classification as a Potential Approach for Attenuation Correction in Whole-Body PET/MRI: Evaluation with PET/CT Data , 2009, Journal of Nuclear Medicine.

[35]  M. Kojima,et al.  Magnetic Resonance Imaging in Peripheral Lung Adenocarcinoma: Correlation With Histopathologic Features , 2009, Journal of thoracic imaging.

[36]  Bernhard Schölkopf,et al.  MRI-Based Attenuation Correction for PET/MRI: A Novel Approach Combining Pattern Recognition and Atlas Registration , 2008, Journal of Nuclear Medicine.

[37]  P. Grigsby,et al.  Intratumoral Metabolic Heterogeneity of Cervical Cancer , 2008, Clinical Cancer Research.

[38]  S. Matsumoto,et al.  Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. , 2008, Radiology.

[39]  P. Boiselle,et al.  Mediastinal Lymph Nodes in Patients With Non-small Cell Lung Cancer: Preliminary Experience With Diffusion-weighted MR Imaging , 2008, Journal of thoracic imaging.

[40]  T. Yen,et al.  Correlation of apparent diffusion coefficients measured by 3T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[41]  J. Hennig,et al.  Hyperecho-Turbo Spin-Echo Sequences at 3T: Clinical Application in Neuroradiology , 2008, American Journal of Neuroradiology.

[42]  S. Shiraishi,et al.  Diffusion-Weighted Magnetic Resonance Imaging for Diagnosing Malignant Pulmonary Nodules/Masses: Comparison with Positron Emission Tomography , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[43]  H. Kato,et al.  Evaluation of chest wall invasion by lung cancer using respiratory dynamic MRI , 2008, Journal of medical imaging and radiation oncology.

[44]  Michael Laniado,et al.  Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions , 2008, European Radiology.

[45]  P. Grigsby,et al.  Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. , 2007, JAMA.

[46]  P. Grigsby,et al.  The standardized uptake value for F‐18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival , 2007, Cancer.

[47]  Y. Ohno,et al.  STIR turbo SE MR imaging vs. coregistered FDG‐PET/CT: Quantitative and qualitative assessment of N‐stage in non‐small‐cell lung cancer patients , 2007, Journal of magnetic resonance imaging : JMRI.

[48]  J. Seo,et al.  3-T MRI: usefulness for evaluating primary lung cancer and small nodules in lobes not containing primary tumors. , 2007, AJR. American journal of roentgenology.

[49]  M. Matoba,et al.  Lung carcinoma: diffusion-weighted mr imaging--preliminary evaluation with apparent diffusion coefficient. , 2007, Radiology.

[50]  Maximilian F Reiser,et al.  MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA. , 2007, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[51]  Heinrich R Schelbert,et al.  Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[52]  Abass Alavi,et al.  Is PET-CT the only option? , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[53]  J. Debatin,et al.  Detection of pulmonary nodules using a 2D HASTE MR sequence: comparison with MDCT. , 2005, AJR. American journal of roentgenology.

[54]  D. Sahani,et al.  Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET. , 2005, AJR. American journal of roentgenology.

[55]  R. Munden,et al.  CT, MR, and PET imaging in staging of non-small-cell lung cancer. , 2005, Seminars in roentgenology.

[56]  R. Hubner,et al.  Fast T1- and T2-weighted pulmonary MR-imaging in patients with bronchial carcinoma. , 2005, European journal of radiology.

[57]  Thomas Beyer,et al.  Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  Y. Ohno,et al.  Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging. , 2004, Radiology.

[59]  W. Oyen,et al.  PET/CT: panacea, redundancy, or something in between? , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[60]  Mark Bydder,et al.  Magnetic Resonance: An Introduction to Ultrashort TE (UTE) Imaging , 2003, Journal of computer assisted tomography.

[61]  Steven M. Larson,et al.  PET/CT: a new imaging technology in nuclear medicine , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[62]  R Weissleder,et al.  Imaging of mediastinal lymph nodes: CT, MR, and FDG PET. , 1998, Radiographics : a review publication of the Radiological Society of North America, Inc.

[63]  J Szumowski,et al.  Two‐point Dixon technique for water‐fat signal decomposition with B0 inhomogeneity correction , 1997, Magnetic resonance in medicine.

[64]  B J McNeil,et al.  CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. , 1991, Radiology.